August 26, 2025

Recurrent Strokes, Headaches: What’s Your Diagnosis?

A 34-year-old woman presented with recurrent ischemic strokes and right-sided headaches. Magnetic resonance imaging revealed multiple right frontoparietal infarcts, and angiography demonstrated bilateral narrowing of the intracranial carotid arteries. What’s your diagnosis?

Conexiant

August 25, 2025

Baricitinib Aids Eyebrow, Eyelash Regrowth in Alopecia Areata

This study highlights baricitinib’s effectiveness in promoting eyebrow and eyelash regrowth in patients with alopecia areata across two phase III clinical trials.

Conexiant

August 25, 2025

Did Politics Delay CDC Measles Response?

Emails and interviews show CDC scientists were sidelined during the West Texas surge, leaving local officials without guidance as cases spread across the US and into Mexico.

KFF Health News

August 22, 2025

Nemolizumab Study Tracks 68 Weeks of Relief

A long-term clinical study finds that the biologic therapy nemolizumab, when used with topical corticosteroids, continues to improve itch, sleep, and skin symptoms in prurigo nodularis patients over 68 weeks.

Conexiant

August 22, 2025

New CT Score Tracks Pneumonia Stage Progression

Researchers validate a visual CT scoring system designed to improve classification of pneumonia-related lung changes in clinical and research settings.

Conexiant

August 21, 2025

Six Evidence-Based Strategies Transform Clinical Listening

New research identifies six practical approaches to values-driven listening that enhance patient trust, reduce burnout, and improve care quality.

Conexiant

August 20, 2025

Frailty Risk High in PRISm Patients

Frailty screening emerges as a critical consideration in PRISm patients as new findings reveal overlapping systemic vulnerabilities with COPD, despite preserved lung function ratio.

Conexiant

August 19, 2025

AAP Vaccine Recommendations Veer From ACIP

AAP released 2025 evidence-based US childhood and adolescent immunization schedule with updates for RSV, influenza, COVID-19, HPV, and meningococcal vaccines.

Conexiant

August 18, 2025

Early Risdiplam Use in Presymptomatic SMA Infants

Presymptomatic treatment with risdiplam was associated with improved motor development and survival without permanent ventilation in infants with spinal muscular atrophy (SMA), according to 24-month results from the phase 2 RAINBOWFISH trial published in the New England Journal of Medicine.

Conexiant